AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 92 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,057,000 | +181.0% | 638,472 | +106.1% | 0.00% | +100.0% |
| Q3 2016 | $4,646,000 | +66.8% | 309,722 | +20.3% | 0.00% | – |
| Q2 2016 | $2,786,000 | +76.2% | 257,509 | +120.8% | 0.00% | – |
| Q1 2016 | $1,581,000 | -28.2% | 116,601 | -2.3% | 0.00% | – |
| Q4 2015 | $2,201,000 | -16.3% | 119,295 | +14.8% | 0.00% | – |
| Q3 2015 | $2,631,000 | – | 103,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |